MEFV and amyloidosis: In another study of FMF-positive Armenians, 0% of migrants living in the United States developed amyloidosis, while for FMF-positive Armenians living in Armenia, the rate exceeded 25%.29 We believe that future studies of FMF patients should focus on which environmental factors play a role in the pathogenesis of FMF.